EL7.AI
StocksMedium•28 October 2026•
3 min read

Teladoc Posts $26.9 Million Third-Quarter Loss as Revenue Falls 3%

Key Facts

1Teladoc revenue was $605.1 million in the third quarter of 2026, down 3%, and it recorded a net loss of $26.9 million, or $0.15 per share.
2Q2 reported revenue of $225.8 million, up 12%, and net income of $33.2 million, compared with $15.0 million a year earlier.
3Q2 raised its 2026 revenue guidance to a range of $888–892 million and adjusted EBITDA guidance to $258–262 million.
4Raymond James posted record fiscal 2026 annual revenue of $15.79 billion and record net income of $2.37 billion.

Teladoc Health reported third-quarter 2026 revenue of $605.1 million, down 3% year over year, and a net loss of $26.9 million, or $0.15 per share. The company said consolidated revenue came near the high end of its guidance range and adjusted EBITDA exceeded its range. The measure was $79.4 million, up 14% from the year-earlier period. The results show a divergence between the company's two segments: integrated care grew, while its direct-to-consumer mental health business continued to contract. The company provided ranges for its full-year outlook but did not say in its statement that it had raised them.

Integrated Care revenue was $398.5 million, up 2% year over year, while BetterHelp revenue fell 13% to $206.6 million. The company attributed the divergence to prioritizing insurance-covered care services, alongside a continued decline in users paying out of pocket for BetterHelp services. Growth in Integrated Care supported revenue but did not prevent Teladoc's total sales from declining during the quarter. Adjusted EBITDA rose to $79.4 million from a year earlier, exceeding the range set by management. Teladoc set 2026 revenue at between $2,395 million and $2,441 million, adjusted EBITDA at between $277 million and $303 million, and free cash flow at between $135 million and $165 million.

Q2 Holdings reported third-quarter revenue of $225.8 million, up 12% from the same period last year. GAAP net income rose to $33.2 million, compared with $15.0 million a year earlier. Adjusted EBITDA was $67.8 million, compared with $48.8 million in the third quarter of 2025. The company said revenue and the adjusted measure exceeded the high end of its quarterly guidance. Subscription-based annual recurring revenue also rose 13.5% year over year, and the company signed seven contracts with enterprise and tier-one clients during the quarter. These figures do not establish a comparison with analysts' results, as the comparison in the company's statement was with its own guidance.

Q2 raised its fiscal 2026 guidance, setting revenue at between $888 million and $892 million and adjusted EBITDA at between $258 million and $262 million. The annual range revision follows revenue and adjusted earnings exceeding the high end of quarterly guidance, the company said. In a management change announced alongside the results, Q2 appointed Chief Financial Officer Jonathan Price co-chief executive officer. The financial announcement and leadership change put operating performance and management arrangements among the company's main developments in the quarter. The available information provided no further details on how responsibilities would be divided between the co-chief executives.

In financial services, Raymond James reported results for its fourth fiscal quarter ended September 30, 2026, with net revenue of $4.269 billion, up 15% year over year. Net income available to common shareholders was $666 million, up 10% from the year-earlier quarter. Diluted earnings per share were $3.40, up 15% from $2.95 in the fourth quarter of the previous fiscal year. For fiscal 2026 as a whole, the company posted record net revenue of $15.79 billion and record net income available to common shareholders of $2.37 billion. Annual diluted earnings per share were also a record $11.91, according to the company's statement.